Targeting Regulation of Tryptophan Metabolism for Colorectal Cancer Therapy: a Systematic Review

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2022 May 6

PMID 35518968

Authors

Hong-Lian Zhang

Ai-Hua Zhang

Jian-Hua Miao

Hui Sun

Guang-Li Yan

Fang-Fang Wu

Xi-Jun Wang

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the most malignant cancers resulting from abnormal metabolism alterations. As one of the essential amino acids, tryptophan has a variety of physiological functions, closely related to regulation of immune system, central nervous system, gastrointestinal nervous system and intestinal microflora. Colorectal cancer, a type of high-grade malignancy disease, stems from a variety of factors and often accompanies inflammatory reactions, dysbacteriosis, and metabolic disorders. Colorectal cancer accompanies inflammation and imbalance of intestinal microbiota and affects tryptophan metabolism. It is known that metabolites, rate-limiting enzymes, and ARH in tryptophan metabolism are associated with the development of CRC. Specifically, IDO1 may be a potential therapeutic target in colorectal cancer treatment. Furthermore, the reduction of tryptophan amount is proportional to the poor quality of life for colorectal cancer patients. This paper aims to discuss the role of tryptophan metabolism in a normal organism and investigate the relationship between this amino acid and colorectal cancer. This study is expected to provide theoretical support for research related to targeted therapy for colorectal cancer. Furthermore, strategies that modify tryptophan metabolism, effectively inhibiting tumor progression, may be more effective for CRC treatment.

Citing Articles

Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples.

Avram L, Crisan D, Moldovan R, Bogos L, Iuga C, Andras D Cancers (Basel). 2025; 17(3).

PMID: 39941796 PMC: 11816151. DOI: 10.3390/cancers17030427.

Gut microbial and metabolomics profiles reveal the potential mechanism of fecal microbiota transplantation in modulating the progression of colitis-associated colorectal cancer in mice.

Song Q, Gao Y, Liu K, Tang Y, Man Y, Wu H J Transl Med. 2024; 22(1):1028.

PMID: 39548468 PMC: 11566892. DOI: 10.1186/s12967-024-05786-4.

Predictive modeling of colorectal cancer using exhaustive analysis of microbiome information layers available from public metagenomic data.

Murovec B, Deutsch L, Stres B Front Microbiol. 2024; 15:1426407.

PMID: 39252839 PMC: 11381387. DOI: 10.3389/fmicb.2024.1426407.

Randomized control trial of moderate dose vitamin D alters microbiota stability and metabolite networks in healthy adults.

Wyatt M, Choudhury A, Von Dohlen G, Heileson J, Forsse J, Rajakaruna S Microbiol Spectr. 2024; 12(10):e0008324.

PMID: 39189761 PMC: 11448053. DOI: 10.1128/spectrum.00083-24.

Oat Beta-Glucan as a Metabolic Regulator in Early Stage of Colorectal Cancer-A Model Study on Azoxymethane-Treated Rats.

Wilczak J, Prostek A, Dziendzikowska K, Gajewska M, Kopiasz L, Harasym J Int J Mol Sci. 2024; 25(9).

PMID: 38731854 PMC: 11083532. DOI: 10.3390/ijms25094635.

References

Naxerova K, Reiter J, Brachtel E, Lennerz J, van de Wetering M, Rowan A . Origins of lymphatic and distant metastases in human colorectal cancer. Science. 2017; 357(6346):55-60. PMC: 5536201. DOI: 10.1126/science.aai8515. View

Ock C, Hwang J, Keam B, Kim S, Shim J, Jang H . Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers. Nat Commun. 2017; 8(1):1050. PMC: 5648801. DOI: 10.1038/s41467-017-01018-0. View

Cheng J, Li W, Kang B, Zhou Y, Song J, Dan S . Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells. Nat Commun. 2015; 6:7209. PMC: 4490363. DOI: 10.1038/ncomms8209. View

Zhao L, Ni Y, Su M, Li H, Dong F, Chen W . High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization. Anal Chem. 2017; 89(10):5565-5577. PMC: 5663283. DOI: 10.1021/acs.analchem.7b00660. View

Munn D, Mellor A . IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance. Trends Immunol. 2016; 37(3):193-207. PMC: 4916957. DOI: 10.1016/j.it.2016.01.002. View

Xing W, Xiao Y, Lu X, Zhu H, He X, Huang W . GFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer. Cell Death Differ. 2017; 24(5):929-943. PMC: 5423119. DOI: 10.1038/cdd.2017.50. View

Gao Y, Wang J, Zhou Y, Sheng S, Qian S, Huo X . Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Sci Rep. 2018; 8(1):2732. PMC: 5807317. DOI: 10.1038/s41598-018-21048-y. View

Zhang A, Yan G, Han Y, Wang X . Metabolomics approaches and applications in prostate cancer research. Appl Biochem Biotechnol. 2014; 174(1):6-12. DOI: 10.1007/s12010-014-0955-6. View

Vieira A, Abar L, Chan D, Vingeliene S, Polemiti E, Stevens C . Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol. 2017; 28(8):1788-1802. DOI: 10.1093/annonc/mdx171. View

10.

Islam J, Sato S, Watanabe K, Watanabe T, Ardiansyah , Hirahara K . Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. J Nutr Biochem. 2017; 42:43-50. DOI: 10.1016/j.jnutbio.2016.12.019. View

11.

Hanninen A, Toivonen R, Poysti S, Belzer C, Plovier H, Ouwerkerk J . induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 2017; 67(8):1445-1453. DOI: 10.1136/gutjnl-2017-314508. View

12.

McGrail D, Federico L, Li Y, Dai H, Lu Y, Mills G . Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers. Nat Commun. 2018; 9(1):1317. PMC: 5882811. DOI: 10.1038/s41467-018-03730-x. View

13.

Wettersten H, Abu Aboud O, Lara Jr P, Weiss R . Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017; 13(7):410-419. DOI: 10.1038/nrneph.2017.59. View

14.

Zhang A, Wang P, Sun H, Yan G, Han Y, Wang X . High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program. Mol Biosyst. 2013; 9(9):2259-65. DOI: 10.1039/c3mb70171a. View

15.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

16.

Cross A, Boca S, Freedman N, Caporaso N, Huang W, Sinha R . Metabolites of tobacco smoking and colorectal cancer risk. Carcinogenesis. 2014; 35(7):1516-22. PMC: 4076812. DOI: 10.1093/carcin/bgu071. View

17.

Li Q, Dai W, Li Y, Xu Y, Li X, Cai S . Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep. 2017; 7:46345. PMC: 5394458. DOI: 10.1038/srep46345. View

18.

Belcheva A, Irrazabal T, Robertson S, Streutker C, Maughan H, Rubino S . Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014; 158(2):288-299. DOI: 10.1016/j.cell.2014.04.051. View

19.

Sun H, Zhang A, Yan G, Piao C, Li W, Sun C . Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics. 2012; 12(3):710-9. PMC: 3591663. DOI: 10.1074/mcp.M112.019141. View

20.

Breda C, Sathyasaikumar K, Sograte Idrissi S, Notarangelo F, Estranero J, Moore G . Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. Proc Natl Acad Sci U S A. 2016; 113(19):5435-40. PMC: 4868470. DOI: 10.1073/pnas.1604453113. View